Detailed information for compound 1543130

Basic information

Technical information
  • TDR Targets ID: 1543130
  • Name: ethyl 6-methyl-4-(4-phenylpiperazin-1-yl)furo [5,4-d]pyrimidine-5-carboxylate
  • MW: 366.414 | Formula: C20H22N4O3
  • H donors: 0 H acceptors: 3 LogP: 3.61 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCOC(=O)c1c(C)oc2c1c(ncn2)N1CCN(CC1)c1ccccc1
  • InChi: 1S/C20H22N4O3/c1-3-26-20(25)16-14(2)27-19-17(16)18(21-13-22-19)24-11-9-23(10-12-24)15-7-5-4-6-8-15/h4-8,13H,3,9-12H2,1-2H3
  • InChiKey: KPJHKIOMVFWDRV-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 6-methyl-4-(4-phenyl-1-piperazinyl)-5-furo[5,4-d]pyrimidinecarboxylic acid ethyl ester
  • 6-methyl-4-(4-phenylpiperazin-1-yl)furo[5,4-d]pyrimidine-5-carboxylic acid ethyl ester
  • E946-0041
  • NCGC00126753-01

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens SMAD family member 2 Starlite/ChEMBL No references
Homo sapiens nuclear factor, erythroid 2-like 2 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) transcription factor SMAD2 Get druggable targets OG5_131716 All targets in OG5_131716
Loa Loa (eye worm) MH2 domain-containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Brugia malayi MH2 domain containing protein Get druggable targets OG5_131716 All targets in OG5_131716
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi MH2 domain containing protein SMAD family member 2 467 aa 405 aa 31.6 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) transcription factor SMAD2 0.0144 1 1
Echinococcus granulosus WD repeat containing protein 48 0.0111 0.7541 1
Loa Loa (eye worm) hypothetical protein 0.0111 0.7541 0.7541
Loa Loa (eye worm) MH2 domain-containing protein 0.0144 1 1
Entamoeba histolytica hypothetical protein 0.0043 0.2503 0.5
Entamoeba histolytica hypothetical protein 0.0043 0.2503 0.5
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0043 0.2503 0.3319
Echinococcus multilocularis WD repeat containing protein 48 0.0111 0.7541 1
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0043 0.2503 0.3319
Schistosoma mansoni transcription factor LCR-F1 0.0043 0.2503 0.628
Entamoeba histolytica hypothetical protein 0.0043 0.2503 0.5
Schistosoma mansoni hypothetical protein 0.0048 0.2825 0.7088
Schistosoma mansoni hypothetical protein 0.0048 0.2825 0.7088
Entamoeba histolytica hypothetical protein 0.0043 0.2503 0.5
Schistosoma mansoni hypothetical protein 0.0043 0.2503 0.628
Toxoplasma gondii hypothetical protein 0.0063 0.3985 0.5
Schistosoma mansoni hypothetical protein 0.0063 0.3985 1
Brugia malayi hypothetical protein 0.0043 0.2503 0.2503
Brugia malayi Hypothetical WD-repeat protein F35G12.4 in chromosome III 0.0111 0.7541 0.7541

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 3.5481 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference
Potency (functional) 16.3601 uM PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] ChEMBL. No reference
Potency (functional) 31.6228 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 79.4328 uM PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.